Literature DB >> 1415928

Operative management of greater saphenous thrombophlebitis involving the saphenofemoral junction.

J M Lohr1, D T McDevitt, K S Lutter, L R Roedersheimer, M G Sampson.   

Abstract

Forty-three consecutive patients with greater saphenous vein (GSV) thrombosis extending to the saphenofemoral junction (SFJ) were treated. Twenty-three patients had extension of thrombus into the common femoral vein (CFV). Twenty patients had thrombus extending to but not within the CFV. Symptoms, risk factors, and physical examination were not predictive of CFV thrombus extension. When compared with the operative record, duplex scans accurately located the extent of the thrombosis 100% of the time. Forty-one surgical procedures were performed. No patients had pulmonary emboli during the procedures. Thirty-seven patients were treated as outpatients or were discharged within 3 days of their surgical procedures. The two patients who did not undergo operative procedures in this series had complete occlusion of the CFV with extension into the external iliac vein. Thrombus within 3 cm of the SFJ is an indication for surgical intervention. Disconnection of the GSV from the CFV prevents extension of the thrombus, and a limited CFV thrombectomy can be performed when necessary. This is considerably more cost-effective than treatment with anticoagulation.

Entities:  

Mesh:

Year:  1992        PMID: 1415928     DOI: 10.1016/s0002-9610(05)81084-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Superficial thrombophlebitis followed by pulmonary embolism.

Authors:  A Huang; K S Hindle
Journal:  J R Soc Med       Date:  2001-07       Impact factor: 5.344

2.  A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis.

Authors:  S W Rathbun; C E Aston; T L Whitsett
Journal:  J Thromb Haemost       Date:  2012-05       Impact factor: 5.824

Review 3.  Superficial venous thrombosis: disease progression and evolving treatment approaches.

Authors:  Maria E Litzendorf; Bhagwan Satiani
Journal:  Vasc Health Risk Manag       Date:  2011-08-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.